# COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults

> **NCT05950776** · PHASE2 · WITHDRAWN · sponsor: **Universitätsklinikum Hamburg-Eppendorf**

## Conditions studied

- Covid19

## Interventions

- **BIOLOGICAL:** MVA-SARS-2-S
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05950776
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01-15
- **Primary completion:** 2022-11-02
- **Final completion:** 2022-11-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Results from Phase 1 lead to the decision
- **Last updated:** 2023-07-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05950776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05950776, "COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05950776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*